SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA (Karvy Fintech Private Limited) regarding loss of share certificate(s) from the following shareholders(s). A copy of intimation from RTA is enclosed herewith. Suven Life inks pact to buy assets of Rising Pharma units
Suven Life Sciences Ltd has entered into an agreement to buy the assets of Aceto Corporation's Rising Pharmaceuticals through its joint venture partne SUVEN LIFE SCIENCES LTD. - 530239 - Outcome of Board Meeting
1. Approved the creation of Wholly Owned Subsidiary (WOS) Suven Pharma, Inc a Delaware Company in USA under CRAMS Division. 2. Approved investment of 75 Mn USD in the said WOS for new business opportunities and acquisitions etc., Suven Life Sciences enters asset purchase agreement to buy Rising Pharma
This potential acquisition of Rising's assets would transform Shore Suven Pharma into a strong US generic pharmaceutical company Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven announces the asset purchase agreement of Rising Pharmaceuticals through its joint venture partner, Shore Suven Pharma Inc. SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
With reference to above subject, pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of Board of Directors of our Company will be held on Saturday, the 9th March, 2019 at 12:00 Noon at the Registered Office, SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad, Telangana, India - 500034, to consider inter alia, and take on record the following matter(s): To consider and approve the investments in new overseas subsidiary and other matters, if any. Please further note that TRADING WINDOW for dealing in the securities of the company is closed from 5th March, 2019 to 11th March, 2019 (both days inclusive) as per PIT Code of the Company. Trading window will be opened from 12th March, 2019. SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Saturday, The 9Th March, 2019 - Reg
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2019 ,inter alia, to consider and approve With reference to above subject, pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of Board of Directors of our Company will be held on Saturday, the 9th March, 2019 at 12:00 Noon at the Registered Office, SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad, Telangana, India - 500034, to consider inter alia, and take on record the following matter(s): To consider and approve the investments in new overseas subsidiary and other matters, if any. Please further note that TRADING WINDOW for dealing in the securities of the company is closed from 5th March, 2019 to 11th March, 2019 (both days inclusive) as per PIT Code of the Company. Trading window will be opened from 12th March, 2019. Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement confirming dispatch of Notice of Postal Ballot and e-Voting Information SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Further to the outcome of meeting of the board of directors of the Company dated February 5, 2019, we hereby enclose a copy of the postal ballot notice dated February 5,2019 ('Postal Ballot Notice') and postal ballot form. SUVEN LIFE SCIENCES LTD. - 530239 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Suven Life Sciences Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.